Avenue Therapeutics, Inc. (ATXI) News
Filter ATXI News Items
ATXI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ATXI News From Around the Web
Below are the latest news stories about AVENUE THERAPEUTICS INC that investors may wish to consider to help them evaluate ATXI as an investment opportunity.
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual MeetingMIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Amy Chappell, M.D., FAAN, will be presenting preclinical in vivo data evaluating BAER-101 using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy at the American Epilepsy Society (AE |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! |
Why Is Avenue Therapeutics (ATXI) Stock Up 59% Today?Avenue Therapeutics stock is rising higher on Wednesday following news of an investor taking a 14.5% stake in ATXI shares. |
Why Is Leslie’s (LESL) Stock Down 24% Today?Leslie's stock is falling hard on Wednesday as investors in LESL react to it missing EPS estimates in Q4 and posting weak 2024 guidance. |
Why Is Seelos Therapeutics (SEEL) Stock Down 42% Today?Seelos Therapeutics stock is falling on Wednesday after the company announced and priced a public offering for shares of SEEL. |
Why Is Wheeler Real Estate IT (WHLR) Stock Up 37% Today?Wheeler Real Estate IT stock is rising higher on Wednesday after the company announced plans to distribute unregistered shares of WHLR stock. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayPre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! |
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights- Phase 1b/2a clinical trial of AJ201 remains on track to report topline data in second quarter of 2024 - - Positive BAER-101 preclinical data accepted for presentation at American Epilepsy Society (AES) Annual Meeting - - Agreement reached with U.S. FDA on study design and analysis approach for Phase 3 safety study of IV tramadol - - Raised $5 million in gross proceeds from public equity offering - MIAMI, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or th |
Avenue Therapeutics' US$4.5m Market Cap Fall Books Insider LossesInsiders who bought US$251.0k worth of Avenue Therapeutics, Inc.'s ( NASDAQ:ATXI ) stock at an average buy price of... |